←Back to Expert Scholars
Translational Medicine / 转化医学ADC Payload Innovation
Puja Sapra
PhD
🏢Pfizer🌐USA
Vice President, ADC Platform
38
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Puja Sapra is a leading ADC scientist who has advanced novel payload platforms including immunostimulatory and non-cytotoxic payloads. Her research on ADC pharmacology and optimization of drug-to-antibody ratios has improved therapeutic indices. She has contributed to the development of next-generation ADC platforms with enhanced tumor selectivity.
Share:
🧪Research Fields 研究领域
ADC platform development
Novel payload classes
Immunostimulatory payloads
ADC pharmacology
Preclinical ADC optimization
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Puja Sapra 的研究动态
Follow Puja Sapra's research updates
留下邮箱，当我们发布与 Puja Sapra（Pfizer）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment